Drug Trial Radar · NCT00773201
Genetic Sources of Variability of the Adaptation of the Ventricular Repolarisation
Last checked: Nov 19, 2026Latest source record: Jul 26, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
997
Actual
Start
Feb 2008
Primary completion
Mar 2012
Study completion Mar 2012
Sponsor
- Lead sponsor
- Assistance Publique - Hôpitaux de ParisAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Oct 16, 2008
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 60 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The main objective is to research for genetic factors involved in the extreme modifications of the QT interval of the electrocardiogram in answer to a pharmacological stimulation (sotalol) and physiological stimulation in the apparently normal general population. The phenotypic characterization, based on the ventricular repolarisation dynamics will be used aiming at term of the predictive genetic factors of the acquired long QT syndrome
Conditions
- Healthy Volunteers
Interventions
Sotalol 80 mgDrug
healthy subjects will receive an unique dose of Sotalol and will have an effort test on ergonomic bicycle, an auditive stimulation and a taking of DNA
Primary outcomes
What the sponsor says the trial is designed to measure.
- The elongation of the corrected interval QT duration 3 hours after the unique oral taking of an 80 mg dose of Sotalol.Time frame: 3 hours after the taking of Sotalol
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Centre d'investigation clinique; Hôpital Saint Antoine
Paris, France
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.